Navigation Links
Biomodels Expands Efforts in Cancer Supportive Care, Pulmonary Fibrosis; Preclinical Research Organization Names Dr. Stephen T. Sonis as Partner
Date:7/22/2009

is, osteonecrosis, cancer treatment-related thrombosis, gastrointestinal toxicity, pulmonary fibrosis, and salivary gland changes.

Dr. Sonis is widely recognized for his studies on the molecular and cellular pathogensis of mucositis, which have resulted in identifying a number of promising pharmaceutical targets to alleviate this universal and incapacitating side of effects of cancer treatment.

He has served as chief medical officer of Biomodels since it was founded in 1997, and holds appointments with the Harvard School of Dental Medicine, the Dana-Farber Cancer Institute, and Brigham and Women's Hospital.

He is the author of more than 100 original publications, 40 reviews and chapters, and seven books. Dr. Sonis serves on a number of editorial boards, and is a founding member of the International Society of Oral Oncology.

About Biomodels

Biomodels (www.biomodels.com), a preclinical contract research organization founded in 1997, has developed and conducted preclinical studies for biotechnology and pharmaceutical companies, particularly in the areas of cancer, cancer supportive care, radiation, therapy, and inflammatory diseases.

The company specializes in (non-GLP) predictive studies that evaluate efficacy and define mechanism of action, enabling clients to expedite the drug discovery process. Biomodels' preclinical studies anticipate clinical objectives and enable organizations to rapidly achieve preclinical milestones.

Photo available upon request.


'/>"/>
SOURCE Biomodels LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ATS Medical Expands Open Pivot Heart Valve Offerings
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. BioLife Solutions Expands Scientific Advisory Board
4. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
5. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
6. Pharsight Expands Strategic Consulting Services Team
7. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
8. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
9. AQUISS Expands Into Significant New Territory
10. NanoBio Expands Drug Development Team for Its Anti-Infective Products
11. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Reportlinker.com announces that a new ... catalogue: ,, The Future of ... 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The author ... of Orphan Diseases Therapeutics - Market Forecasts ...
(Date:12/15/2009)... and CHARLOTTESVILLE, Va., Dec. 15 ... the University of Virginia (UVa) in Charlottesville, ... a strategic research collaboration to enhance development ... disease (CAD) with a secondary focus on ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The collaborative preclinical ...
(Date:12/15/2009)... --The Mosaic Company (NYSE: MOS ) plans ... results and financial tables on Tuesday, January 5, 2010, ... Stock Exchange. Results will be available on Mosaic,s ... host a conference call with presentation slides on Wednesday, ... call will begin at 11:00 a.m. Eastern Standard Time ...
(Date:12/15/2009)... PHILADELPHIA, Dec. 15 The Center ... Advanstar Communications, is pleased to announce the ... Pharmaceutical/Biotech Accounting and Reporting Congress . The ... Philadelphia, on March 16-17, 2010. ,, Over ... professionals have attended this premier event since ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2
... China, Sept. 5 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-,Pharmaceutical Technology, ... developer and producer of plant extracts and pharmaceutical ... production in,Xi,an, China, is pleased to announce a ... with Xi,an Qinba Xintong Medical Ltd. ("Qinba").,Under the ...
... MATEO, Calif., Sept. 4 BioForm Medical,Inc. (Nasdaq: BFRM ... full fiscal year ended June 30, 2008. Net sales were ... to $15.4 million,for the quarter ended June 30, 2007, an ... million for the quarter ended June 30, 2008 as,compared to ...
... COLUMBUS, Ohio, Sept. 4 The Ohio State ... country to discuss,translating scientific breakthroughs in the laboratory ... Health Care Conference on,Oct. 16-17., Health care ... experts, academic leaders, and consumer and patient,advocacy groups ...
Other Biology Technology:Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xi'an Qinba Xintong Medical Ltd. 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 4BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 5BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 6BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 7BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 8BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 9OSU to Host National Personalized Health Care Conference 2
(Date:12/14/2009)... founded a new journal Cardiovascular Engineering and Technology ... a forum for research on all aspects of cardiovascular ... the new quarterly journal will appear in March 2010 ... Annals of Biomedical Engineering and Cellular and ... will present a wide spectrum of research, from ...
(Date:12/14/2009)... are spending the holidays with big Uncle Frank or ... better off with another family, spare a thought for ... from McMaster University and the University of New South ... lives in groups, members make strategic decisions about their ... current issue of Biology Letters . , The ...
(Date:12/14/2009)... thought of tool use as a defining feature of humans. ... primates, along with birds and an array of other mammals. ... Current Biology , a Cell Press publication, adds an octopus ... octopus under study manages a behavioral trick that the researchers ... over stacked, upright coconut shell "bowls," makes its eight arms ...
Breaking Biology News(10 mins):Biomedical Engineering Society's new journal to be published by Springer 2Tool use in an invertebrate: The coconut-carrying octopus 2American Cancer Society Hope Lodges Sign 29th Contract to Implement SoftBrands Systems 53503 1American Cancer Society Hope Lodges Sign 29th Contract to Implement SoftBrands Systems 53503 2Human Genome Sciences Announces Closing of Public Offering 13334 1Human Genome Sciences Announces Closing of Public Offering 13334 2Human Genome Sciences Announces Closing of Public Offering 13334 3National Institutes of Health Chooses Web of Science 28R 29 to Power electronic Scientific Portfolio Assistant 28eSPA 29 13333 1National Institutes of Health Chooses Web of Science 28R 29 to Power electronic Scientific Portfolio Assistant 28eSPA 29 13333 2
... Bulletin Board: BKYI) today announced plans to release first quarter,2008 ... opens.,In conjunction with the release, BIO-key has scheduled a conference ... May 15, 2008 at,9:00 a.m. Eastern Time., What: ... Call ...
... What if hydrology is more important for predicting biodiversity ... the journal Nature challenges current thinking about biodiversity and ... or human activity may affect biodiversity patterns. , ... that the biodiversity of fish species in a river ...
... of the genome sequence of the duck-billed platypus was ... clues about how genomes were organized during the early ... by the National Human Genome Research Institute (NHGRI), part ... of TV nature shows will remember that the duck-billed ...
Other Biology News:BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule 2Biodiversity -- it's in the water 2Duck-billed platypus genome sequence published 2Duck-billed platypus genome sequence published 3Duck-billed platypus genome sequence published 4
Coating : Poly-D-Lysine ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vol working : 2.5-3.0 ml ...
Rabbit polyclonal to Synapsin II ( Abpromise for all tested applications). entrezGeneID: 6854 SwissProtID: Q92777...
... These primers are designed for sequencing ... the SP6, T7, or T3 RNA polymerase ... They are supplied at a concentration of ... functionally tested in DNA sequencing reactions using ...
... powerful application for DNA and protein ... Expression makes complex computational analyses of ... the very latest computing technology to ... sequences are analysed. Features include: Sequence ...
Biology Products: